U.S. technology companies reported their Q4 2025 results after the Wall Street close today. Most companies (Tesla didn't) beat consensus estimates on both earnings and revenue, supporting the US100, which recovered losses following Powell’s remarks. After the releases, Meta Platforms and Tesla are up more than 4%, Microsoft is down nearly 3%, and IBM is up almost 7%.
Source: xStation5
Meta Platforms: Q4 2025 results (META.US; up 4% after-hours)
-
EPS: $8.88 vs $8.19 est. vs $8.02 a year ago
-
Revenue: $59.89B vs $58.42B est.
-
Advertising revenue: $58.14B vs $56.79B est.
-
Family of Apps revenue: $58.94B vs $57.47B est.
-
Family of Apps operating income: $30.77B vs $30.0B est.
-
Total operating income: $24.75B, +5.9% y/y
-
Reality Labs revenue: $955M vs $962.7M est.
-
Reality Labs operating loss: $6.02B vs $5.8B est. (loss)
-
Commercial remaining performance obligation (cRPO): $625B
-
Q1 revenue guidance: $53.5B–$56.5B vs $51.27B est.
-
2026 capex guidance: $115B–$135B vs $110.62B est.
Source: xStation5
Microsoft: Q2 2026 results (MSFT.US; down 3% after-hours)
-
Adjusted EPS: $4.14 vs $3.92 est.
-
Revenue: $81.27B vs $80.31B est.
-
-
Intelligent Cloud revenue: $32.91B vs $32.39B est.
-
Azure & other cloud services (ex-FX): +38% vs +38% est.
-
Productivity and Business Processes revenue: $34.12B vs $33.45B est.
-
More Personal Computing revenue: $14.25B vs $14.33B est.
-
Commercial remaining performance obligation (cRPO): $625B
-
Microsoft 365 (commercial seats): +6%
-
Operating income: $38.28B vs $36.55B est.
-
Capital expenditures (CAPEX): $29.88B vs $23.78B est.
-
Revenue at constant currency: +15% vs +14.3% est.
-
Source: xStation5
Source: Bloomberg Finance L.P., XTB Research
Tesla: Q4 2025 results (TSLA.US; up 4% after-hours)
-
Adjusted EPS: $0.50 vs $0.45 est.
-
EPS: $0.24 vs $0.66 a year ago
-
Revenue: $24.90B vs $25.11B est.
-
Operating income: $1.41B vs $1.32B est.
-
Gross margin: 20.1% vs 17.1% est.
-
Free cash flow (FCF): $1.42B vs $1.59B est.
Source: xStation5
IBM: Q4 2025 results (IBM.US; up 7% after-hours)
-
Operating EPS: $4.52 vs $4.28 est.
-
Revenue: $19.69B vs $19.21B est.
-
Software revenue: $9.03B vs $8.82B est.
-
Consulting revenue: $5.35B vs $5.38B est.
-
Free cash flow (FCF): $7.55B vs $6.85B est.
-
FY revenue outlook (constant currency): above +5% vs +4.12% est.
-
FY FCF outlook: expected to increase by about $1B y/y
Source: xStation5
Daily Summary – Bessent Rescues the Dollar, Fed Delivers Hawkish Pivot
BREAKING: FED maintains the rates!↔️🚨
US OPEN: All-time high and expectations ahead of the Fed
What can we expect from Meta's Q4 2025 results? Advertising, AI, and the price of aggressive growth
The material on this page does not constitute as financial advice and does not take into account your level of understanding, investment objectives, financial situation or any other particular needs.
All the information provided, including opinions, market research, mathematical results and technical analyses published on the website or transmitted to you by other means is provided for information purposes only and should in no event be interpreted as an offer of, or solicitation for, a transaction in any financial instrument, nor should the information provided be construed as advice of legal or fiscal nature.
Any investment decisions you make shall be based exclusively on your level of understanding, investment objectives, financial situation or any other particular needs. Any decision to act on information published on the website or transmitted to you by other means is entirely at your own risk. You are solely responsible for such decisions.
If you are in doubt or are not sure that you understand a particular product, instrument, service, or transaction, you should seek professional or legal advice before trading.
Investing in OTC Derivatives carries a high degree of risk, as they are leveraged based products and often small movements in the market could lead to much larger movements in the value of your investment and this could work against you or for you. Please ensure that you fully understand the risks involved, taking into account your investments objectives and level of experience, before trading, and if necessary, seek independent advice.
